共有 50 笔近期内部人交易记录记录，涉及 Replimune Group, Inc. (REPL), 包括 21 笔买入 和 24 笔卖出. 内部人买入总额为 $8.05M 内部人卖出总额为 $2.07M.
近期活跃的重要内部人包括 Sarchi Christopher, Astley-sparke Philip, Hill Emily Luisa. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.
内部人交易记录 — REPL
| 日期 |
姓名 |
职位 |
交易类型 |
股数 |
平均价格 |
总价值 |
持股数量 |
| 2026-04-02 |
Sarchi Christopher |
Chief Commercial Officer |
知情卖出 |
6,500 |
$8.01 |
$52.07K |
151,588 |
| 2026-02-18 |
Astley-sparke Philip |
Director |
赠与（送出） |
25,000 |
- |
- |
1,380,071 |
| 2025-12-19 |
Hill Emily Luisa |
Chief Financial Officer |
限制性股票授予 (RSU) |
60,000 |
- |
- |
194,368 |
| 2025-12-19 |
Patel Sushil |
Chief Executive Officer |
限制性股票授予 (RSU) |
200,000 |
- |
- |
533,576 |
| 2025-12-19 |
Xynos Konstantinos |
Chief Medical Officer |
限制性股票授予 (RSU) |
60,000 |
- |
- |
199,685 |
| 2025-12-19 |
Schwendenman Andrew |
Chief Accounting Officer |
限制性股票授予 (RSU) |
10,000 |
- |
- |
78,284 |
| 2025-12-19 |
Sarchi Christopher |
Chief Commercial Officer |
限制性股票授予 (RSU) |
35,000 |
- |
- |
158,088 |
| 2025-12-09 |
Dhingra Kapil |
Director |
知情卖出 |
3,169 |
$10.40 |
$32.96K |
- |
| 2025-12-02 |
Patel Sushil |
Chief Executive Officer |
知情卖出 |
10,000 |
$11.13 |
$111.3K |
333,576 |
| 2025-11-17 |
Xynos Konstantinos |
Chief Medical Officer |
知情卖出 |
7,248 |
$9.10 |
$65.96K |
139,685 |
| 2025-11-17 |
Sarchi Christopher |
Chief Commercial Officer |
知情卖出 |
5,208 |
$9.10 |
$47.39K |
123,088 |
| 2025-08-15 |
Hill Emily Luisa |
Chief Financial Officer |
知情卖出 |
9,154 |
$5.37 |
$49.16K |
134,368 |
| 2025-05-20 |
Astley-sparke Philip |
Director |
知情卖出 |
32,279 |
$8.06 |
$260.17K |
1,405,071 |
| 2025-05-20 |
Hill Emily Luisa |
Chief Financial Officer |
知情卖出 |
2,535 |
$8.05 |
$20.41K |
143,522 |
| 2025-05-20 |
Patel Sushil |
Chief Executive Officer |
知情卖出 |
25,105 |
$8.06 |
$202.35K |
343,576 |
| 2025-05-20 |
Xynos Konstantinos |
Chief Medical Officer |
知情卖出 |
7,952 |
$8.06 |
$64.09K |
146,933 |
| 2025-05-20 |
Schwendenman Andrew |
Chief Accounting Officer |
知情卖出 |
3,287 |
$8.05 |
$26.46K |
68,284 |
| 2025-05-20 |
Sarchi Christopher |
Chief Commercial Officer |
知情卖出 |
3,749 |
$8.05 |
$30.18K |
128,296 |
| 2025-04-01 |
Slattery Joseph P |
Director |
限制性股票授予 (RSU) |
32,000 |
$8.40 |
$268.8K |
32,000 |
| 2025-04-01 |
Pucci Paolo |
Director |
限制性股票授予 (RSU) |
32,000 |
$8.40 |
$268.8K |
32,000 |
| 2025-04-01 |
Dhingra Kapil |
Director |
限制性股票授予 (RSU) |
32,000 |
$8.40 |
$268.8K |
32,000 |
| 2025-04-01 |
Balachandran Madhavan |
Director |
限制性股票授予 (RSU) |
32,000 |
$8.40 |
$268.8K |
32,000 |
| 2025-04-01 |
Weinand Dieter |
Director |
限制性股票授予 (RSU) |
32,000 |
$8.40 |
$268.8K |
32,000 |
| 2025-04-01 |
Hill Emily Luisa |
Chief Financial Officer |
限制性股票授予 (RSU) |
67,500 |
$8.40 |
$567K |
67,500 |
| 2025-04-01 |
Oliger Christy J. |
Director |
限制性股票授予 (RSU) |
32,000 |
$8.40 |
$268.8K |
32,000 |
| 2025-04-01 |
Patel Sushil |
Chief Executive Officer |
限制性股票授予 (RSU) |
250,000 |
$8.40 |
$2.1M |
250,000 |
| 2025-04-01 |
Xynos Konstantinos |
Chief Medical Officer |
限制性股票授予 (RSU) |
67,500 |
$8.40 |
$567K |
67,500 |
| 2025-04-01 |
Schwendenman Andrew |
Chief Accounting Officer |
限制性股票授予 (RSU) |
50,000 |
$8.40 |
$420K |
50,000 |
| 2025-04-01 |
Peeples-dyer Veleka |
Director |
限制性股票授予 (RSU) |
32,000 |
$8.40 |
$268.8K |
32,000 |
| 2025-04-01 |
Sarchi Christopher |
Chief Commercial Officer |
限制性股票授予 (RSU) |
67,500 |
$8.40 |
$567K |
67,500 |
| 2025-03-05 |
Baker Bros. Advisors Lp |
10 Percent Owner |
未知 |
4,102,636 |
- |
- |
- |
| 2025-03-05 |
Baker Bros. Advisors Lp |
10 Percent Owner |
限制性股票授予 (RSU) |
64,000 |
$12.29 |
$786.56K |
64,000 |
| 2025-03-05 |
Goller Michael |
Officer |
未知 |
- |
- |
- |
- |
| 2024-12-16 |
Patel Sushil |
Chief Executive Officer |
知情卖出 |
10,000 |
$12.42 |
$124.2K |
202,014 |
| 2024-11-18 |
Xynos Konstantinos |
Chief Medical Officer |
知情卖出 |
7,246 |
$10.78 |
$78.11K |
109,885 |
| 2024-11-18 |
Sarchi Christopher |
Chief Commercial Officer |
知情卖出 |
5,207 |
$10.78 |
$56.13K |
87,045 |
| 2024-09-04 |
Balachandran Madhavan |
Director |
未知 |
- |
- |
- |
- |
| 2024-09-04 |
Balachandran Madhavan |
Director |
限制性股票授予 (RSU) |
64,000 |
$10.44 |
$668.16K |
64,000 |
| 2024-08-30 |
Astley-sparke Philip |
Executive Chairman |
赠与（送出） |
50,000 |
- |
- |
1,437,350 |
| 2024-08-16 |
Hill Emily Luisa |
Chief Financial Officer |
知情卖出 |
8,938 |
$10.18 |
$90.99K |
101,057 |
| 2024-06-07 |
Xynos Konstantinos |
Chief Medical Officer |
知情卖出 |
15,881 |
$7.50 |
$119.11K |
117,131 |
| 2024-05-16 |
Astley-sparke Philip |
Executive Chairman |
知情卖出 |
37,928 |
$6.47 |
$245.39K |
1,487,350 |
| 2024-05-16 |
Coffin Robert |
Director |
知情卖出 |
11,464 |
$6.47 |
$74.17K |
1,821,872 |
| 2024-05-16 |
Love Colin |
Chief Operating Officer |
知情卖出 |
17,615 |
$6.47 |
$113.97K |
777,345 |
| 2024-05-16 |
Patel Sushil |
Chief Executive Officer |
知情卖出 |
20,194 |
$6.47 |
$130.66K |
212,014 |
| 2024-05-16 |
Xynos Konstantinos |
Chief Medical Officer |
知情卖出 |
6,367 |
$6.47 |
$41.19K |
133,012 |
| 2024-05-16 |
Schwendenman Andrew |
Chief Accounting Officer |
知情卖出 |
2,298 |
$6.47 |
$14.87K |
38,238 |
| 2024-05-16 |
Sarchi Christopher |
Chief Commercial Officer |
知情卖出 |
2,218 |
$6.47 |
$14.35K |
92,252 |
| 2024-04-01 |
Slattery Joseph P |
Director |
限制性股票授予 (RSU) |
32,000 |
$7.73 |
$247.36K |
32,000 |
| 2024-04-01 |
Levitsky Hyam |
Director |
限制性股票授予 (RSU) |
32,000 |
$7.73 |
$247.36K |
32,000 |
■ 知情交易 — 公开市场买卖（最具参考价值）
■ 非知情买入 — 奖励、期权行权、转换
■ 非知情卖出 — 税务代扣、归属出售
■ 中性 — 礼赠、信托、到期
